Comments to FDA: Contract Manufacturing Quality Agreements Share page: Docket Number: FDA-2013-D-0558 CHPA's comments on this Draft Guidance are organized into three General Comments and Detailed Comments by Section. Download Document Issues: OTC Medicines Other Issues Quality Related Posts Comments Comments Regarding Control of Nitrosamine Impurities in Human Drugs Dec 20, 2024 Press Releases and Statements Rates for Teen Abuse of OTC Cough/Cold Medication Remains Low According to NIDA Survey Dec 18, 2024 Pediatric Cough/Cold Dosing